Free UK delivery on orders over £50·Next Day available·Shipping info
KLOW 80mg
Peptide

KLOW 80mg

Advanced research-grade peptide blend synthesised to pharmaceutical purity standards.

£60
per vial · research use only
Purity
≥98%
Form
Lyophilised Powder
Storage
-20°C
Code
KLOW80
Research GradeBlendPeptideAdvanced

What is KLOW80?

KLOW 80mg is an advanced proprietary peptide blend formulated by Helix Biotech for researchers requiring a high-purity, multi-component research compound. Synthesised to pharmaceutical-grade standards, KLOW 80mg is designed for laboratory investigations into complex peptide interactions and synergistic biological pathways.

Key Features

  • Pharmaceutical-grade synthesis and purity
  • Independently verified components
  • Consistent batch-to-batch formulation
  • Full COA available on request

Mechanism of Action

The KLOW 80mg blend combines complementary peptide sequences that act on overlapping biological pathways. Each component is independently verified for identity and purity before blending, ensuring consistent and reproducible results across research applications. The lyophilised format preserves peptide integrity and bioactivity for extended periods.

Research Applications

  • Multi-target peptide interaction studies
  • Synergistic pathway investigation
  • Advanced laboratory peptide research
  • Comparative efficacy studies

Reconstitution Guide

Reconstitute with sterile bacteriostatic water. Gently swirl to dissolve. Store at 2–8°C after reconstitution.

Research Use Only. For research use only. Not for human or veterinary use. All products are intended solely for in vitro research and laboratory use. Helix Biotech does not endorse, encourage, or condone the use of any research compounds in humans or animals.

Helix Biotech

Advanced research compounds for scientific investigation. All products are intended for laboratory research purposes only.

Research Use Only Disclaimer: All products sold by Helix Biotech are intended for research purposes only. Not for human consumption. These products are not medicines or drugs and have not been approved by the MHRA or any regulatory authority for therapeutic use. Must be handled by qualified researchers in appropriate laboratory settings. Helix Biotech accepts no liability for misuse of research compounds.

© 2026 Helix Biotech Ltd. All rights reserved. Registered in England & Wales.

Research Grade · UK Dispatch · Batch Verified